Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Current Opinion in Biotechnology
|
November 3, 2005
Innovation and greater probability of success in drug discovery and development -- from target to biomarkers
Ismail Kola, Daria Hazuda
Positively Aware : the Monthly Journal of the Test Positive Aware Network
|
May 23, 2014
Exploring possibilities
Daria Hazuda, Mike Miller, Jeff Berry
Annual Review of Pharmacology and Toxicology
|
October 22, 2008
Emerging pharmacology: inhibitors of human immunodeficiency virus integration
Daria Hazuda, Marian Iwamoto, Larissa Wenning
ACS Infectious Diseases
|
October 18, 2019
Rational Design of Doravirine: From Bench to Patients
Carey Hwang, Ming-Tain Lai, Daria Hazuda
Current Opinion in Chemical Biology
|
May 21, 2013
Next generation therapeutics
Paul J Carter, Daria Hazuda, James A Wells
AIDS Research and Human Retroviruses
|
February 26, 2009
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid
Nancie M Archin, Amy Espeseth, Daniel Parker, et al.
Plos One
|
March 31, 2011
siRNA screening of a targeted library of DNA repair factors in HIV infection reveals a role for base excision repair in HIV integration
Amy S Espeseth, Rick Fishel, Daria Hazuda, et al.
The Journal of Infectious Diseases
|
July 12, 2021
Letter to the Editor in Response to Zhou et al
Sean Troth, Joan Butterton, Carisa Stadlman DeAnda, et al.
Science (New York, N.Y.)
|
March 7, 2009
The challenge of finding a cure for HIV infection
Douglas D Richman, David M Margolis, Martin Delaney, et al.
Journal of Virology
|
September 7, 2007
Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate
Krishan K Pandey, Sibes Bera, Jacob Zahm, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Current Opinion in Biotechnology
|
November 3, 2005
Innovation and greater probability of success in drug discovery and development -- from target to biomarkers
Ismail Kola, Daria Hazuda
Positively Aware : the Monthly Journal of the Test Positive Aware Network
|
May 23, 2014
Exploring possibilities
Daria Hazuda, Mike Miller, Jeff Berry
Annual Review of Pharmacology and Toxicology
|
October 22, 2008
Emerging pharmacology: inhibitors of human immunodeficiency virus integration
Daria Hazuda, Marian Iwamoto, Larissa Wenning
ACS Infectious Diseases
|
October 18, 2019
Rational Design of Doravirine: From Bench to Patients
Carey Hwang, Ming-Tain Lai, Daria Hazuda
Current Opinion in Chemical Biology
|
May 21, 2013
Next generation therapeutics
Paul J Carter, Daria Hazuda, James A Wells
AIDS Research and Human Retroviruses
|
February 26, 2009
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid
Nancie M Archin, Amy Espeseth, Daniel Parker, et al.
Plos One
|
March 31, 2011
siRNA screening of a targeted library of DNA repair factors in HIV infection reveals a role for base excision repair in HIV integration
Amy S Espeseth, Rick Fishel, Daria Hazuda, et al.
The Journal of Infectious Diseases
|
July 12, 2021
Letter to the Editor in Response to Zhou et al
Sean Troth, Joan Butterton, Carisa Stadlman DeAnda, et al.
Science (New York, N.Y.)
|
March 7, 2009
The challenge of finding a cure for HIV infection
Douglas D Richman, David M Margolis, Martin Delaney, et al.
Journal of Virology
|
September 7, 2007
Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate
Krishan K Pandey, Sibes Bera, Jacob Zahm, et al.
Page
of 6